Where does Justin Hanes work?

Justin Hanes is Venture Partner at Catalio Capital Management, LP and Manager of Company at Ashvattha Therapeutics.

What does Justin Hanes invest in?

Justin Hanes invests in Biotech.

What check size does Justin Hanes write?

Justin Hanes typically writes checks of $100K – $5M.

Where did Justin Hanes go to school?

Justin Hanes studied at Massachusetts Institute of Technology (Ph.D., Chemical Engineering); UCLA (BS, Chemical Engineering).

Justin Hanes

Investor

Venture Partner at Catalio Capital Management, LP · Manager of Company at Ashvattha Therapeutics

Baltimore, Maryland

Writes $100K – $5M checks · typically $1.5M

About

Justin Hanes serves as Director of the Center of Nanomedicine at Johns Hopkins Medicine, with a research focus on nanomedicine. He holds a BS from the University of California Los Angeles and a PhD from the Massachusetts Institute of Technology. He was elected to the National Academy of Inventors in 2014 and named to MIT Technology Review's 35 Innovators Under 35 in 2003.

Invests in

Biotech

Manager of Company at Ashvattha Therapeutics

Intro paths

→

In turn, Justin can intro founders to Ashvattha Therapeutics's investors below.

Ashvattha Therapeutics's investors · 1

Catalio Capital Management, LPNew York

Co-founders at Ashvattha Therapeutics

Jeffrey ClelandManager of Company

Kannan RangaramanujamManager of Company

Sujatha KannanManager of Company

Experience

Theraly, Inc.Foundercurrent2014 — presentBaltimore, MD
Theraly Diabetes, Inc.Foundercurrent2014 — presentBaltimore, MD
GrayBug, LLCFounder, Director, and Former CEO (2011-2013)current2011 — presentBaltimore, MD
Kala PharmaceuticalsFounder and Former Director (2009-2012)current2009 — presentGreater Boston
Wilmer Eye InstituteLewis J. Ort Professorcurrent2009 — present
Johns Hopkins UniversityLewis J. Ort Family Professorcurrent1998 — presentBaltimore, MD

Skills & more

Drug Delivery65Lifesciences28Biotechnology56R&D21Drug Development16Drug Discovery12Technology Transfer23Molecular Biology16Biomedical Engineering7Nanotechnology16Immunology3Chemistry10

+8 more

BiomaterialsPharmaceutical IndustryCell CultureCommercializationCellLife SciencesBiochemistryCell Biology

From Justin's professional profile.

Investments

Investor

Advanced Inhalation ResearchAshvattha TherapeuticsCivitas TherapeuticsGrayBug VisionKala PharmaceuticalsNeuralyOrpherisSpiral TherapeuticsTheraly Fibrosis

Per the firm's website.

Colleagues at Catalio Capital Management, LP

Adam Riess

Venture Partner at Catalio Capital Management, LP

Alan Ashworth

Venture Partner at Catalio Capital Management, LP

Christine E. 'Kricket' Seidman

Venture Partner at Catalio Capital Management, LP

Dan Littman

Venture Partner at Catalio Capital Management, LP

David Sinclair

Venture Partner at Catalio Capital Management, LP

Diamantis Xylas

Analyst at Catalio Capital Management, LP

Frances H. Arnold

Venture Partner at Catalio Capital Management, LP

Freda Lewis-Hall

Venture Partner at Catalio Capital Management, LP

Frequently asked questions

Who is Justin Hanes?: Justin Hanes serves as Director of the Center of Nanomedicine at Johns Hopkins Medicine, with a research focus on nanomedicine. He holds a BS from the University of California Los Angeles and a PhD from the Massachusetts Institute of Technology. He was elected to the National Academy of Inventors in 2014 and named to MIT Technology Review's 35 Innovators Under 35 in 2003.
Where does Justin Hanes work?: Justin Hanes is Venture Partner at Catalio Capital Management, LP and Manager of Company at Ashvattha Therapeutics.
What does Justin Hanes invest in?: Justin Hanes invests in Biotech.
What check size does Justin Hanes write?: Justin Hanes typically writes checks of $100K – $5M.
What companies has Justin Hanes invested in?: Investments tracked here include Advanced Inhalation Research, Ashvattha Therapeutics, Civitas Therapeutics, GrayBug Vision, Kala Pharmaceuticals, Neuraly, Orpheris, Spiral Therapeutics, Theraly Fibrosis.
Where did Justin Hanes go to school?: Justin Hanes studied at Massachusetts Institute of Technology (Ph.D., Chemical Engineering); UCLA (BS, Chemical Engineering).

Same school

Also attended Massachusetts Institute of Technology1,387

Fred WilsonCo-founder & Partner at Union Square Ventures Elad GilSolo general partner investing through Gil Capital Aileen LeeFounder & Managing Partner of Cowboy Ventures Hemant TanejaCEO & Managing Director of General Catalyst Nat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDG Brad FeldCo-founder of Foundry and Techstars

+ 1,381 more

Also attended UCLA499

Ben HorowitzCo-founder & General Partner at Andreessen Horowitz Ron ConwayFounder of SV Angel Kirsten GreenFounder and Managing Partner at Forerunner Ventures Vlad TenevCo-founder & CEO of Robinhood Ryan KingCo-founder of Chime Paul FieldingFinance & Operations at General Catalyst

+ 493 more

Shared employers

Also worked at Kala Pharmaceuticals3

Robert PaullCo-Founder and Venture Partner at Lux Capital Eddie EltoukhyPartner at Pear VC Kevin BittermanPartner at Atlas Venture

Also worked at Johns Hopkins University57

Demi ObayomiPrincipal at Sapphire Ventures Jun JeonInvestor at Khosla Ventures Linda CuretonBoard Member at Maryland TEDCO David NarrowVenture Advisor at Cultivation Capital Charlie BuffaVice President, Sales at Mainsail Partners Oluwakayode (Kay) JasanyaInvestor at SUPPLY CHANGE CAPITAL

+ 51 more